On Tuesday, the Federal Trade Commission released its second interim staff report on prescription drug middlemen. The report examines the impact of PBMs (specifically CVS Caremark, Express Scripts and Optum Rx) on specialty generic drugs, highlighting substantial price markups by PBMs on medications for cancer, HIV and other conditions.
This new eBook by Elation Health offers a check list to help primary care practices maintain and grow in the face of these challenges. Elation shares insights that can also improve operational efficiencies and long-term sustainability.
Providence spun off its venture capital arm and renamed it Allumia Ventures. The newly independent venture capital firm also recently closed its third fund, in which Providence invested $150 million. Allumia is looking to grow the fund by inviting 3-5 other health systems to be limited partner investors.
The good news is that virtual solutions are becoming more sophisticated every day to eliminate these care deserts. These promising strategies are helping.
AI/big data haven't solved healthcare's challenges. Despite advancements, systemic barriers persist, but AI offers potential to improve outcomes and efficiency.
Combining AI-driven insights with tailored care pathways, patients gain access to health coaches, psychologists, and treatment plans, while providers benefit from workflow optimization.
In this episode, we're joined by Kathryn Schubert, president and CEO of the Society for Women's Health Research. Schubert discusses the trends in women's health that defined 2024 and what we can expect in the coming year.
No comments